Capital International Inc. CA Has $26.17 Million Position in Mettler-Toledo International, Inc. $MTD

Capital International Inc. CA boosted its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 5.6% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 21,318 shares of the medical instruments supplier’s stock after purchasing an additional 1,122 shares during the period. Capital International Inc. CA owned about 0.10% of Mettler-Toledo International worth $26,170,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Versant Capital Management Inc boosted its stake in shares of Mettler-Toledo International by 42.1% during the 3rd quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock valued at $33,000 after buying an additional 8 shares during the period. SJS Investment Consulting Inc. increased its stake in shares of Mettler-Toledo International by 2,700.0% in the third quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock worth $34,000 after acquiring an additional 27 shares during the last quarter. Salomon & Ludwin LLC acquired a new position in shares of Mettler-Toledo International in the third quarter worth $43,000. Root Financial Partners LLC purchased a new stake in shares of Mettler-Toledo International during the third quarter worth $42,000. Finally, MV Capital Management Inc. boosted its position in Mettler-Toledo International by 50.0% during the second quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock valued at $42,000 after purchasing an additional 12 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Stock Down 1.5%

Shares of NYSE MTD opened at $1,230.50 on Wednesday. Mettler-Toledo International, Inc. has a 12 month low of $946.69 and a 12 month high of $1,525.17. The company has a market cap of $25.02 billion, a P/E ratio of 29.21, a P/E/G ratio of 2.62 and a beta of 1.43. The business’s 50 day moving average is $1,391.20 and its two-hundred day moving average is $1,371.17.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, February 5th. The medical instruments supplier reported $13.36 earnings per share for the quarter, beating the consensus estimate of $12.76 by $0.60. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.The company had revenue of $1.13 billion during the quarter, compared to analysts’ expectations of $1.10 billion. During the same period in the prior year, the business earned $12.41 earnings per share. Mettler-Toledo International’s revenue for the quarter was up 8.1% compared to the same quarter last year. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. Sell-side analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

MTD has been the topic of a number of recent research reports. The Goldman Sachs Group assumed coverage on Mettler-Toledo International in a research note on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 target price on the stock. Bank of America upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price target for the company in a report on Monday, December 15th. Barclays lowered their price target on Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating for the company in a research note on Monday, December 15th. Morgan Stanley dropped their price objective on Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating on the stock in a report on Tuesday, February 10th. Finally, Wall Street Zen raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Saturday, February 14th. Six investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $1,435.42.

Insider Activity

In other news, CFO Shawn Vadala sold 800 shares of the company’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the completion of the transaction, the chief financial officer owned 5,288 shares of the company’s stock, valued at approximately $7,456,714.56. This represents a 13.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.77% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.